From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

IFN- ${gamma}$ Release Assays vs. TST for Predicting Development of Active TB

Among individuals exposed to TB, 14.6% of those with a positive IFN- ${gamma}$ release assay developed active TB, compared with only 2.3% of those with a positive tuberculin skin test.

Welcome to Journal Watch. The content you requested requires sign in with a username and password.

Sign In

Sign Up

Print subscribers

Activate your free online account for full access to all site content and features.

Other visitors

Subscribe for full access to all site content and features. ($99/year)

Purchase a site pass for full access to all articles. ($19/7 days)

Or, simply register for free access to email alerts, site features, and article archives. (FREE)

For more details on site access options, read more...